JONESBORO, Ark. (KAIT) – The first trial doses of an Alzheimer’s vaccine will be available at a Boston hospital this week. The study will enroll 16 participants between the ages of 60 and 85, all of whom have early-stage Alzheimer’s but are otherwise generally healthy.
Alzheimer’s is a disease that causes memory loss, confusion, and even anger. It’s a disease that Jonesboro-born Kevin Richardson felt firsthand.
“It was one of the most painful things I’ve ever been through,” said Richardson. He watched his father fight Alzheimer’s for years.
He said the hardest part was watching his father go through personality changes. Part of the disease that he didn’t know existed. He said his father didn’t know what was going on, which was difficult for him.
“Sometimes that scared look was just unbearable,” said Richardson.
Peggy Killian, vice president of communications for the Alzheimer’s Association, says the vaccine was a long time coming.
“It’s exciting because it means more learning,” said Killian.
Alzheimer’s is something she has studied for years and says there is still so much we don’t know.
Copyright 2021 KAIT. All rights reserved.